Drug Trial Radar · NCT06035354
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AK120 in Subjects With Atopic Dermatitis
Last checked: Nov 19, 2026Latest source record: Mar 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
427
Actual
Start
Nov 3, 2021
Primary completion
Jun 21, 2024
Study completion Jun 21, 2024
Sponsor
- Lead sponsor
- AkesoIndustry
- Sponsor type
- Industry
- First posted
- Sep 13, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, placebo-controlled, multicenter phase Ib/II clinical study to evaluate the safety, pharmacokinetics and efficacy of AK120 in the treatment of subjects with moderate to severe atopic dermatitis.
Conditions
- Atopic Dermatitis
Interventions
AK120Drug
subcutaneous injection once a week
AK120Drug
subcutaneous injection once a week
PlaceboDrug
subcutaneous injection once a week.
AK120Drug
subcutaneous injection every 2 weeks.
AK120Drug
subcutaneous injection every 2 weeks.
AK120Drug
subcutaneous injection every 2 weeks.
PlaceboDrug
subcutaneous injection every 2 weeks for 16 weeks then crossover to AK120 Regimen 4 and Regimen 5.
AK120Drug
subcutaneous injection every 2 weeks
AK120Drug
subcutaneous injection every 2 weeks.
AK120Drug
subcutaneous injection every 2 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase IbTime frame: Baseline to week 12
- Phase IbTime frame: Baseline to week 12
- Phase IbTime frame: Baseline to week 12
- Phase IbTime frame: Baseline to week 12
- Phase IbTime frame: Baseline to week 12
- Phase IITime frame: at week 16
- Phase II Extension StudyTime frame: Baseline to week 24
Locations
39 sites in 1 country. Site status is shown where the registry gives one.
AkesoBio Investigative Site 2037, The First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, China
AkesoBio Investigative Site 2036, The First Affiliated Hospital of Wannan Medical College
Wuhu, Anhui, China
AkesoBio Investigative Site 1001, Peking University People's Hospital
Beijing, Beijing Municipality, China
AkesoBio Investigative Site 2044, Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
AkesoBio Investigative Site 2023, Xinqiao Hospital Medical University
Chongqing, Chongqing Municipality, China
AkesoBio Investigative Site 2024, Chongqing Three Gorges Medical College
Chongqing, Chongqing Municipality, China
AkesoBio Investigative Site 2040, Chongqing Traditional Chinese Medicine Hospital
Chongqing, Chongqing Municipality, China
AkesoBio Investigative Site 2052, The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
AkesoBio Investigative Site 2038, The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
AkesoBio Investigative Site 2022, Dongguan People's Hospital
Dongguan, Guangdong, China
AkesoBio Investigative Site 1002, Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China
AkesoBio Investigative Site 2003, Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China
AkesoBio Investigative Site 2049, The Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, China
AkesoBio Investigative Site 2004, The First Affiliated Hospital of Hainan Medical University
Haikou, Hainan, China
AkesoBio Investigative Site 2001, Affiliated Hospital of Chengde medical university
Chengde, Hebei, China
AkesoBio Investigative Site 2010, Nanyang First People's Hospital National Third Class A Hospital
Nanyang, Henan, China
AkesoBio Investigative Site 2051, Jingzhou Central Hospital
Jingzhou, Hubei, China
AkesoBio Investigative Site 1005, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
AkesoBio Investigative Site 2046, The Third Xiangya Hospital of Central South University
Changsha, Hunan, China
AkesoBio Investigative Site 2008, The Affiliated Hospital of Inner Mongolia Medical University
Hohhot, Inner Mongolia, China
AkesoBio Investigative Site 2048, The First People's Hospital of Changzhou
Changzhou, Jiangsu, China
AkesoBio Investigative Site 2050, Wuxi Second People's Hospital
Wuxi, Jiangsu, China
AkesoBio Investigative Site 2025, Affiliated Hospital of Jiangsu University
Zhenjiang, Jiangsu, China
AkesoBio Investigative Site 2032, The First Affiliated Hospital of Gannan Medical College
Ganzhou, Jiangxi, China
AkesoBio Investigative Site 2011, Northeast International Hospital
Shenyang, Liaoning, China
AkesoBio Investigative Site 2039, Shandong Provincial Dermatology Hospital
Jinan, Shandong, China
AkesoBio Investigative Site 2041, Qilu Hospital of Shandong University
Jinan, Shandong, China
AkesoBio Investigative Site 1003, Shanghai Skin Disease Hospital
Shanghai, Shanghai Municipality, China
AkesoBio Investigative Site 2027, Medical School of Yanan University
Xianyang, Shanxi, China
AkesoBio Investigative Site 2029, West China Hospital,Sichuan University
Chengdu, Sichuan, China
AkesoBio Investigative Site 2034, Chengdu Second People's Hospital
Chengdu, Sichuan, China
AkesoBio Investigative Site 2013, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital
Tianjin, Tianjin Municipality, China
AkesoBio Investigative Site 2019, Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, China
AkesoBio Investigative Site 2043, First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
AkesoBio Investigative Site 1004, Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China
AkesoBio Investigative Site 2006,Affiliated Hangzhou First People's Hospital
Hangzhou, Zhejiang, China
AkesoBio Investigative Site 2007, Hangzhou Third People's Hospital
Hangzhou, Zhejiang, China
AkesoBio Investigative Site 2035, The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
AkesoBio Investigative Site 2009, The First Hospital of Jiaxing
Jiaxing, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.